<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02931240</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-0066</org_study_id>
    <nct_id>NCT02931240</nct_id>
  </id_info>
  <brief_title>BioVentrix Revivent TC™ System Clinical Study</brief_title>
  <official_title>Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioVentrix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioVentrix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multi-center, dual-arm pivotal study of the BioVentrix Revivent TC System,&#xD;
      with 2:1 study vs. active concurrent control group allocation ratio. This study will include&#xD;
      126 patients of which 84 patients will be treated with the investigational device and 42&#xD;
      patients will be included in an active control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Revivent TC System is indicated for patients referred for surgical treatment of left&#xD;
      ventricular scar that is contiguous, and includes both anterior and septal components.&#xD;
      Primary and Secondary Effectiveness Endpoints will compare data from the patients treated&#xD;
      with the Revivent TC System to a control pool of patients who comply with all aspects of the&#xD;
      protocol except scar location and are not treated with the investigational devices but remain&#xD;
      on Guideline Directed Medical Therapy (GDMT). The primary safety and effectiveness endpoints&#xD;
      will be evaluated at 12 months post procedure. The study will be conducted at a maximum of 20&#xD;
      clinical centers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 29, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of all cause death, mechanical support, emergent cardiac surgery, prolonged mechanical ventilation, renal failure and clinically important stroke compared to data from the STS database for surgical LV aneurysm repair.</measure>
    <time_frame>1 Month</time_frame>
    <description>Composite primary safety endpoint of all cause death, placement of a mechanical support device intra or post-op (IABP, VAD, ECMO or catheter based), emergent cardiac surgery including reoperation for bleeding or tamponade, prolonged mechanical ventilation, renal failure and clinically important stroke (Rankin Score of 4 or higher) through 30-days post procedure. Data from the patients treated with the Revivent TC System will be compared to surgical outcomes data from the Society for Thoracic Surgery database for surgical LV aneurysm repair.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The rate of all cause of death, mechanical support, and operation (or re-operation) for HF, bleeding or tamponade from 1 through 12 months post procedure compared to untreated patients who remain on Guideline Directed Medical Therapy (GDMT).</measure>
    <time_frame>1 Year</time_frame>
    <description>A composite of all cause of death, placement of a mechanical support device and operation (or re-operation) for HF, bleeding or tamponade from 1 through 12 months (day 31 through 365) post procedure. Data from patients treated with the Revivent TC System will be compared to data from a control pool of patients who comply with all aspects of the protocol except scar (aneurysm) location and are not treated with the investigational devices remain on Guideline Directed Medical Therapy (GDMT). Patients in the GDMT group will be evaluated from day 31 through 365 after the date of enrollment into the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The rate of re-hospitalization and improvement of HF Symptoms in patients treated with the test device compared to patients who are maintained on Guideline Directed Medical Therapy.</measure>
    <time_frame>1 year</time_frame>
    <description>Composite primary effectiveness endpoint consisting of:&#xD;
No hospital readmission for new or worsening heart failure, and&#xD;
Improvement in MLHF Quality of Life score by &gt;10 points, and&#xD;
Improvement in 6 Minute Walk Distance by &gt;25 meters, and&#xD;
Improvement in NYHA Classification &gt; 1 grade.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Ventricular Dysfunction, Left</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with the Revivent TC System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Pool</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Treatment with Guideline Directed Medical Therapy for Heart Failure Symptoms Only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Revivent TC</intervention_name>
    <description>Treatment of LV scar</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years old or older&#xD;
&#xD;
          -  LV Aneurysm or Scar Presence: Defined by presence of a contiguous acontractile&#xD;
             (akinetic and/or dyskinetic) scar;&#xD;
&#xD;
          -  LV Aneurysm/Scar Location: Defined as a scar involving septum and/or anterior, apical&#xD;
             or anterolateral regions of the left ventricle as evidenced by cardiac imaging and&#xD;
             referred for surgical management;&#xD;
&#xD;
          -  Viability of myocardium in regions remote from area of intended scar exclusion as&#xD;
             evidenced by cardiac imaging;&#xD;
&#xD;
          -  Left Ventricular Ejection Fraction &lt; 45%;&#xD;
&#xD;
          -  Left ventricular end-systolic volume index ≥50 mL/m2;&#xD;
&#xD;
          -  Suffering from heart failure symptoms as defined by NYHA Classification &gt; 2 not&#xD;
             responsive to medical therapy;&#xD;
&#xD;
          -  Patient completed 6 Minute Walk Test and MLHF Quality of Life Questionnaire (can be&#xD;
             performed at baseline visit);&#xD;
&#xD;
          -  Patient is on adequate Guideline Directed Medical Therapy (GDMT);&#xD;
&#xD;
          -  Subject or a legally authorized representative must provide written informed consent;&#xD;
&#xD;
          -  Agree to required follow-up visits; and&#xD;
&#xD;
          -  Female subject of childbearing potential does not plan pregnancy for at least one year&#xD;
             following the index procedure. For a female of childbearing potential, a pregnancy&#xD;
             test must be performed with negative results known within seven days prior to index&#xD;
             procedure Candidates for the study group must meet ALL of the inclusion criteria.&#xD;
&#xD;
        Candidates allocated to active concurrent control pool of patients must meet all inclusion&#xD;
        criteria (including LV Aneurysm/Scar Presence), WITH THE EXCEPTION OF ONE OF THE FOLLOWING:&#xD;
&#xD;
          -  They have undergone previous pericardiotomy, left thoracotomy, or open heart surgery,&#xD;
             or&#xD;
&#xD;
          -  The LV Aneurysm/Scar location does not permit treatment with the study device, or&#xD;
&#xD;
          -  The patient elects to be enrolled in the control group&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Candidates will be excluded from the study and active concurrent control group if ANY of&#xD;
        the following conditions are present:&#xD;
&#xD;
          -  Cardiac Resynchronization Therapy (CRT) or ICD pacing lead placement ≤ 60 days prior&#xD;
             to enrollment;&#xD;
&#xD;
          -  Valvular heart disease, which in the opinion of the investigator, will require&#xD;
             surgery;&#xD;
&#xD;
          -  Functional Mitral Regurgitation greater than moderate (i.e. EROA&gt;20mm sq.) and&#xD;
             degenerative MR (including MR due to papillary muscle rupture);&#xD;
&#xD;
          -  Need for coronary revascularization, in the opinion of the site investigator;&#xD;
&#xD;
          -  Peak Systolic Pulmonary Arterial Pressure &gt; 60 mm Hg via echo or right heart&#xD;
             catheterization and/or evidence of cor pulmonale;&#xD;
&#xD;
          -  Myocardial Infarction within 90 days prior to enrollment;&#xD;
&#xD;
          -  Within the last six months, a prior CVA or TIA, or any intracranial hemorrhage, or any&#xD;
             permanent neurologic deficit, or any known intracranial pathology;&#xD;
&#xD;
          -  Co-morbid disease process with life expectancy of less than one year or active&#xD;
             malignancy not in remission;&#xD;
&#xD;
          -  Any solid organ transplant or is on waiting list for any solid organ transplant other&#xD;
             than cardiac;&#xD;
&#xD;
          -  Chronic renal failure with a serum creatinine &gt;2.5 mg/dL and/or GFR&lt;30ml/min;&#xD;
&#xD;
          -  Subject is currently participating in another clinical trial that has not yet&#xD;
             completed its primary endpoint;&#xD;
&#xD;
          -  Presence of significant ventricular arrhythmias&#xD;
&#xD;
        The following exclusion criteria apply only to the treatment group and do not apply to the&#xD;
        concurrent control cohort:&#xD;
&#xD;
          -  Contraindication or inability to adhere to systemic anticoagulation;&#xD;
&#xD;
          -  Known hypersensitivity or contraindication to device materials;&#xD;
&#xD;
          -  Previous pericardiotomy or left thoracotomy;&#xD;
&#xD;
          -  Pathology/previous surgery/radiation therapy of the right neck that would interfere&#xD;
             with placement of a 14F delivery catheter;&#xD;
&#xD;
          -  Prior open heart surgery or significant pericarditis;&#xD;
&#xD;
          -  Calcified ventricular wall in the area of intended anchor implants as verified by&#xD;
             cardiac imaging;&#xD;
&#xD;
          -  Thrombus or intra-ventricular mass in the left atrium or ventricle as verified by&#xD;
             cardiac imaging that has not been adequately treated with anticoagulant.&#xD;
&#xD;
          -  Functioning pacemaker leads in antero-apical RV, which, in the opinion of the&#xD;
             investigator, would interfere with anchor placement;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew S Wechsler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Drexel University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregg W Stone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerry D Estep, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Noel Messenger, MBA</last_name>
    <phone>(925)830-1000</phone>
    <phone_ext>231</phone_ext>
    <email>nmessenger@bioventrix.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Arizona College of Medicine - Phoenix Banner University Medicine Heart Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Schohn</last_name>
      <phone>419-494-7257</phone>
      <email>James.Schohn@bannerhealth.com</email>
    </contact>
    <investigator>
      <last_name>Radha Gopalan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ronald Regan UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzan Khalil</last_name>
      <phone>310-267-6957</phone>
      <email>skhalil@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Ali Nsair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Nguyen</last_name>
      <phone>415-476-0388</phone>
      <email>Thomas.Nguyen5@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Vaikom Mahadevan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Los Robles Hospital &amp; Medical Center</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mane Arabyan</last_name>
      <phone>805-796-3746</phone>
      <email>Mane.Arabyan@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Saibal Kar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Fontana, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Hospital of Maimi</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria I Ardid</last_name>
      <phone>786-596-6258</phone>
      <email>MariaAR@baptisthealth.net</email>
    </contact>
    <investigator>
      <last_name>Ramon Quesada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chari Ponder, RN</last_name>
      <phone>404-686-3364</phone>
      <email>Chari.ponder@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Kendra Grubb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellStar Health System</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Neese, RSN</last_name>
      <phone>470-793-4065</phone>
      <email>Michele.neese@wellstar.org</email>
    </contact>
    <investigator>
      <last_name>Amar Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62781</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristal Adams</last_name>
      <phone>217-545-7812</phone>
      <email>kadams@siumed.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Hazelrigg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Terrebonne General Medical Center</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicky Parfait, RN</last_name>
      <phone>985-873-5603</phone>
      <email>Vicky.Parfait@cardio.com</email>
    </contact>
    <contact_backup>
      <last_name>Deanna Beniot, RN</last_name>
      <phone>9858735613</phone>
      <email>Deanna.Benoit@cardio.com</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Fail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5856</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neha Shah</last_name>
      <phone>734-232-4606</phone>
      <email>neshah@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Keith Aaronson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamas Alexy, MD</last_name>
      <phone>612-624-6132</phone>
      <email>alexy001@umn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Coley Landvik,, RN</last_name>
      <phone>612-625-3475</phone>
      <email>clandvik@umn.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Huffman, RN</last_name>
      <phone>816-932-0391</phone>
      <email>ahuffman@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Andrew Kao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann TownsendSolis, RN</last_name>
      <phone>551-996-2136</phone>
      <email>Ann.TownsendSolis@hackensackmeridian.org</email>
    </contact>
    <investigator>
      <last_name>Carlos Ruiz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Saint Vrestil</last_name>
      <phone>212-241-9687</phone>
      <email>nicole.saintvrestil@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Samin Sharma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Glum, BSN</last_name>
      <phone>212-746-4617</phone>
    </contact>
    <contact_backup>
      <last_name>Dolores Reynolds</last_name>
      <phone>212 746 4617</phone>
      <email>Hep2011@med.cornell.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Evelyn Horn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Hospital</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Jeanne Wilkerson</last_name>
      <phone>336-713-2500</phone>
      <email>ljwilker@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>David Zhao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Ann Moennich</last_name>
      <phone>216-444-2106</phone>
      <email>moennil@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Rishi Puri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacie Hanes, RN</last_name>
      <phone>405-608-1283</phone>
      <email>shanes@okheart.com</email>
    </contact>
    <investigator>
      <last_name>Mohammad Ghani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Pinnacle</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Rodgers</last_name>
      <phone>717-639-6410</phone>
      <email>Rodgerscl4@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Roberto Hodara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Health Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Chamberlain</last_name>
      <phone>717-531-1452</phone>
      <email>lchamberlain@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Pfeiffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Laverty-Wilson</last_name>
      <phone>215-300-7456</phone>
      <email>Eva.Laverty-Wilson@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Pavan Atluri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburg Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalin Toma, MD</last_name>
      <phone>412-802-3131</phone>
      <email>tomacx@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jenny Whitehead, RN</last_name>
      <phone>412-647-3611</phone>
      <email>whiteheadj5@upmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Everidge</last_name>
      <phone>843-792-2944</phone>
      <email>adamsde@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Baye, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI St. Luke's Health-Baylor St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey Kappenman</last_name>
      <phone>832-355-9179</phone>
      <email>ckappenman@texasheart.org</email>
    </contact>
    <investigator>
      <last_name>Samar Sheth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wajeeha Abrar</last_name>
      <phone>346-238-6402</phone>
      <email>wabrar2@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Dipan Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winchester Medical Center</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Zelaski</last_name>
      <phone>540-536-7542</phone>
      <email>azelaski@valleyhealthlink.com</email>
    </contact>
    <investigator>
      <last_name>Jason Call, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemocnice Na Homolce</name>
      <address>
        <city>Prague</city>
        <zip>150 30</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filip Sklenář</last_name>
      <phone>+420 257 272 993</phone>
      <email>Filip.Sklenar@homolka.cz</email>
    </contact>
    <investigator>
      <last_name>Petr Neužil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hygeia Hospital</name>
      <address>
        <city>Athens</city>
        <zip>151 23</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evgenia Dafnomili</last_name>
      <email>EDafnomili@hygeia.gr</email>
    </contact>
    <investigator>
      <last_name>Konstantinos Spargias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Interbalkan Medical Center</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikoleta Ioannidou</last_name>
      <phone>+302310278889</phone>
      <email>vittoria6182@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Vlasis Ninios, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital NHS Foundation Trust</name>
      <address>
        <city>Cambridge</city>
        <zip>CB23 3RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Saji, RN</last_name>
      <phone>01480 830</phone>
      <email>saji.victor@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Steven Tsui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Jones, RN</last_name>
      <phone>0191 24 48939</phone>
      <email>Samantha.Jones@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Azfar Zaman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Greece</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.bioventrix.com</url>
    <description>Sponsor Web Site</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 30, 2016</study_first_submitted>
  <study_first_submitted_qc>October 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

